RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330

Shiwei Zhou; Obinna N. Obianom; Jiangsheng Huang; Dong Guo; Hong Yang; Qing Li; Yan Shu

doi:10.3390/pharmaceutics15061623

Pharmaceutics (May 2023)

RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330

Shiwei Zhou,
Obinna N. Obianom,
Jiangsheng Huang,
Dong Guo,
Hong Yang,
Qing Li,
Yan Shu

Affiliations

Shiwei Zhou: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
Obinna N. Obianom: Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Jiangsheng Huang: Department of Thyroid Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China
Dong Guo: Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Hong Yang: Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Qing Li: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
Yan Shu: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China

DOI: https://doi.org/10.3390/pharmaceutics15061623
Journal volume & issue: Vol. 15, no. 6
p. 1623

Abstract

Read online

The authors and the journal retract the article, ‘Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation’ [...]

n/a

Published in Pharmaceutics

ISSN: 1999-4923 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Pharmacy and materia medica
Website: http://www.mdpi.com/journal/pharmaceutics/

About the journal

Abstract

Keywords